Digital and Biological Twins in Cholangiocarcinoma: From Translational Research to Precision Medicine—A Narrative Review
Livers · 13.08.2026 · 6 (4) · 80
DOI: 10.3390/livers6040080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Livers, online erschienen am 13.08.2026. Verfasst von Lorenzo Manganaro und 7 weiteren Autor:innen. Die Arbeit nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cholangiocarcinoma (CCA) is a highly heterogeneous malignancy with limited therapeutic options and poor prognosis. The increasing complexity of molecular stratification and treatment selection has stimulated interest in computational and biological modeling approaches for precision oncology.
Objective
This narrative review aims to provide a comprehensive overview of digital twins (DTs), DT-enabling computational models, and biological twins (BTs) in CCA, discussing their applications, limitations, and potential integration within hybrid precision medicine frameworks.
Methods
A narrative literature review was conducted. To inform the twin-focused sections, a structured PubMed search was performed using predefined keywords related to CCA and twin-related technologies, including organoids, xenografts, organ-on-chip systems. Particular attention was devoted to recent studies addressing computational modeling, patient-derived experimental systems, and translational applications.
Results
DT development in CCA is supported by an ecosystem of DT-enabling technologies, including radiomics, artificial intelligence, multi-omics integration, and simulation-based models. However, fully realized medical DTs remain unavailable. BTs, including patient-derived organoids, xenografts, and microfluidic platforms, enable functional validation of therapeutic hypotheses but face challenges related to scalability, standardization, and clinical feasibility. Emerging hybrid DT-BT frameworks seek to combine computational prediction with biological validation through iterative feedback loops, potentially improving patient stratification and treatment personalization.
Conclusions
DTs and BTs represent complementary components of an evolving precision oncology ecosystem in CCA. Although technical, biological, regulatory, and implementation challenges remain, the convergence of computational models, longitudinal molecular monitoring, and patient-derived systems may facilitate clinically actionable hybrid twin frameworks. Successful translation will require both technological innovation and healthcare-system improvements to precision medicine access.
Zitieren
APA
Manganaro, L., Sario, G. D., Carpino, G., Frey, L. J., Gaudio, E., Syn, W., Alvaro, D., & Cardinale, V. (2026). Digital and Biological Twins in Cholangiocarcinoma: From Translational Research to Precision Medicine—A Narrative Review. Livers, 6(4), 80. https://doi.org/10.3390/livers6040080
Vancouver
Manganaro L, Sario GD, Carpino G, Frey LJ, Gaudio E, Syn W, et al. Digital and Biological Twins in Cholangiocarcinoma: From Translational Research to Precision Medicine—A Narrative Review. Livers. 2026;6(4):80. doi:10.3390/livers6040080
BibTeX
@article{Manganaro2026,
author = {Manganaro, Lorenzo and Sario, Giuseppe De and Carpino, Guido and Frey, Lewis J. and Gaudio, Eugenio and Syn, Wing-Kin and Alvaro, Domenico and Cardinale, Vincenzo},
title = {Digital and Biological Twins in Cholangiocarcinoma: From Translational Research to Precision Medicine—A Narrative Review},
journal = {Livers},
year = {2026},
volume = {6},
number = {4},
pages = {80},
doi = {10.3390/livers6040080}
}
EUVIMED